FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Darren Richard

Research Profile

Chemicals & Drugs

Physiology

Anatomy

Living Beings

Rats

Co-author Network

Publications

TOP 3
Caroline M Lambert; Mélanie Roy; Jolyane Meloche; Geneviève A Robitaille; Mohsen Agharazii; Darren E Richard; Sébastien Bonnet
Tumor necrosis factor inhibitors as novel therapeutic tools for vascular remodeling diseases.
Marie-Claude Lauzier; Geneviève A Robitaille; Denise A Chan; Amato J Giaccia; Darren E Richard
(2R)-[(4-Biphenylylsulfonyl)amino]-N-hydroxy-3-phenylpropionamide (BiPS), a matrix metalloprotease inhibitor, is a novel and potent activator of hypoxia-inducible factors.
Elisabeth L Pagé; Denise A Chan; Amato J Giaccia; Mark Levine; Darren E Richard
Hypoxia-inducible factor-1alpha stabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Darren Richard (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Caroline M Lambert; Mélanie Roy; Jolyane Meloche; Geneviève A Robitaille; Mohsen Agharazii; Darren E Richard; Sébastien Bonnet
Tumor necrosis factor inhibitors as novel therapeutic tools for vascular remodeling diseases.
American journal of physiology. Heart and circulatory physiology 2010;299(4):H995-1001.
2008: Marie-Claude Lauzier; Geneviève A Robitaille; Denise A Chan; Amato J Giaccia; Darren E Richard
(2R)-[(4-Biphenylylsulfonyl)amino]-N-hydroxy-3-phenylpropionamide (BiPS), a matrix metalloprotease inhibitor, is a novel and potent activator of hypoxia-inducible factors.
Molecular pharmacology 2008;74(1):282-8.
2008: Elisabeth L Pagé; Denise A Chan; Amato J Giaccia; Mark Levine; Darren E Richard
Hypoxia-inducible factor-1alpha stabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion.
Molecular biology of the cell 2008;19(1):86-94.
2007: Marie-Claude Lauzier; Elisabeth L Pagé; Maude D Michaud; Darren E Richard
Differential regulation of hypoxia-inducible factor-1 through receptor tyrosine kinase transactivation in vascular smooth muscle cells.
Endocrinology 2007;148(8):4023-31.
2006: Marie-Claude Lauzier; Maude D Michaud; Marc-André C Déry; Darren E Richard
[HIF-1 activation during tumor progression: implications and consequences].
Bulletin du cancer 2006;93(4):349-56.
2005: Rebecca Bilton; Nathalie M Mazure; Eric Trottier; Maurice Hattab; Marc-André C Déry; Darren E Richard; Jacques Pouysségur; M Christiane Brahimi-Horn
Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1alpha and is not induced by hypoxia or HIF.
The Journal of biological chemistry 2005;280(35):31132-40.
2005: Marc-André C Déry; Maude D Michaud; Darren E Richard
Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators.
The international journal of biochemistry & cell biology 2005;37(3):535-40.
2004: Caroline C Blouin; Elisabeth L Pagé; Guylaine M Soucy; Darren E Richard
Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha.
Blood 2004;103(3):1124-30.
2002: Elisabeth L Pagé; Geneviève A Robitaille; Jacques Pouysségur; Darren E Richard
Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms.
The Journal of biological chemistry 2002;277(50):48403-9.
2001: Edurne Berra; Danièle Roux; Darren E Richard; Jacques Pouysségur
Hypoxia-inducible factor-1 alpha (HIF-1 alpha) escapes O(2)-driven proteasomal degradation irrespective of its subcellular localization: nucleus or cytoplasm.
EMBO reports 2001;2(7):615-20.
2001: Edurne Berra; Darren E Richard; E Gothié; Jacques Pouysségur
HIF-1-dependent transcriptional activity is required for oxygen-mediated HIF-1alpha degradation.
FEBS letters 2001;491(1-2):85-90.
2000: Edurne Berra; J Milanini; Darren E Richard; Maude Le Gall; F Viñals; E Gothié; Danièle Roux; Gilles Pagès; Jacques Pouysségur
Signaling angiogenesis via p42/p44 MAP kinase and hypoxia.
Biochemical pharmacology 2000;60(8):1171-8.
2000: Darren E Richard; Edurne Berra; Jacques Pouyssegur
Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells.
The Journal of biological chemistry 2000;275(35):26765-71.
2000: Gilles Pagès; J Milanini; Darren E Richard; Edurne Berra; E Gothié; F Viñals; Jacques Pouysségur
Signaling angiogenesis via p42/p44 MAP kinase cascade.
Annals of the New York Academy of Sciences 2000;902():187-200.
2000: E Gothié; Darren E Richard; Edurne Berra; Gilles Pagès; Jacques Pouysségur
Identification of alternative spliced variants of human hypoxia-inducible factor-1alpha.
The Journal of biological chemistry 2000;275(10):6922-7.
1999: Darren E Richard; Edurne Berra; Jacques Pouysségur
Angiogenesis: how a tumor adapts to hypoxia.
Biochemical and biophysical research communications 1999;266(3):718-22.
1999: Darren E Richard; Edurne Berra; E Gothié; Danièle Roux; Jacques Pouysségur
p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1.
The Journal of biological chemistry 1999;274(46):32631-7.